Armistice Capital »

Icon shares owned by Armistice Capital

Quarter-by-quarter ownership of Icon (ICLR) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Icon

Tip: Access up to 7 years of quarterly data

All positions including Icon held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Icon by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.7M 60k 110.66
2024-12-31 $88M 418k 209.71

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Icon

Artisan Partners Limited Partnership
Harris Associates L.P
Wellington Management Company
Invesco
Principal Financial Group
FMR
Brave Warrior Advisors
Massachusetts Financial Services
Sachem Head Capital Management
Greenhaven Associates
Ruane, Cunniff & Goldfarb
Brandes Investment Partners
Alliancebernstein
D. E. Shaw & Co
Trinity Street Asset Management

View all funds holding Icon